Filament Health Corp. (FLHLF)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Dec 23, 2025, 4:00 PM EST
Filament Health Revenue
Filament Health had revenue of 9.51K CAD in the quarter ending September 30, 2025, a decrease of -50.01%. This brings the company's revenue in the last twelve months to 458.54K, down -78.75% year-over-year. In the year 2024, Filament Health had annual revenue of 616.68K, down -71.06%.
Revenue (ttm)
458.54K CAD
Revenue Growth
-78.75%
P/S Ratio
0.08
Revenue / Employee
35.27K CAD
Employees
13
Market Cap
26.18K USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 616.68K | -1.51M | -71.06% |
| Dec 31, 2023 | 2.13M | 1.77M | 484.63% |
| Dec 31, 2022 | 364.50K | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Glass House Brands | 196.17M |
| Global Cord Blood | 196.10M |
| Elite Pharmaceuticals | 122.89M |
| Silence Therapeutics | 25.83M |
| OpGen | 9.00M |
| Northwest Biotherapeutics | 937.00K |
Filament Health News
- 6 months ago - Coca Access and Benefit Sharing Agreement Authorized by Peru's National Institute of Agrarian Innovation (INIA) Supports Research Efforts of Jaguar Health and Filament Health Joint Venture, Magdalena Biosciences, into Potential Mental Health and CNS Indications of Coca - Accesswire
- 11 months ago - Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, to Present February 10th at BIO CEO & Investor Conference - Accesswire
- 1 year ago - Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, to Present January 12 at the Annual Neuroscience Innovation Forum - Accesswire
- 1 year ago - Jaguar Health Announces Import of Coca Leaf From Peru by Joint Venture Magdalena Biosciences for Research in Treating Mental Health Indications - Accesswire
- 1 year ago - Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, to Present October 16 at BIO Investor Forum - Accesswire
- 1 year ago - Key Collaborator of Jaguar Health Joint Venture Magdalena Biosciences Receives Prestigious Alzheimer's Association Award - Accesswire
- 1 year ago - Elaine Elisabetsky, PhD, Member of Jaguar Health's Mental Health Entheogen Therapeutics Initiative, to Speak August 2nd About Plant-Based Medicines Used to Manage Schizophrenia at the University of Illinois Chicago College of Pharmacy - Accesswire
- 1 year ago - Negev Capital Fund One, L.P. Reports Updated Holdings in Filament Health Corp. - Newsfile Corp